Ming Li

7.5k total citations · 1 hit paper
253 papers, 4.5k citations indexed

About

Ming Li is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Ming Li has authored 253 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Pulmonary and Respiratory Medicine, 87 papers in Molecular Biology and 84 papers in Oncology. Recurrent topics in Ming Li's work include Lung Cancer Treatments and Mutations (50 papers), Lung Cancer Diagnosis and Treatment (33 papers) and Cancer-related molecular mechanisms research (31 papers). Ming Li is often cited by papers focused on Lung Cancer Treatments and Mutations (50 papers), Lung Cancer Diagnosis and Treatment (33 papers) and Cancer-related molecular mechanisms research (31 papers). Ming Li collaborates with scholars based in China, United States and Canada. Ming Li's co-authors include Cheng Zhan, Qun Wang, Mengnan Zhao, Yiwei Huang, Tao Lu, Xiaodong Yang, Jiacheng Yin, Jiaqi Liang, Zhencong Chen and Ke Ma and has published in prestigious journals such as Circulation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Ming Li

235 papers receiving 4.5k citations

Hit Papers

<p>Trends in the incidence, treatment, and survival... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Li China 35 1.7k 1.5k 1.3k 1.1k 577 253 4.5k
Yasuhiro Miki Japan 45 2.8k 1.6× 1.1k 0.7× 2.2k 1.6× 1.6k 1.5× 461 0.8× 248 6.7k
Jing Zhang China 31 1.3k 0.8× 885 0.6× 1.4k 1.1× 642 0.6× 354 0.6× 236 4.0k
Yue Liu China 32 2.2k 1.3× 800 0.5× 715 0.5× 984 0.9× 644 1.1× 227 4.3k
Weide Zhong China 40 2.8k 1.6× 1.1k 0.7× 879 0.7× 1.7k 1.5× 490 0.8× 217 4.7k
Yi Liu China 34 2.4k 1.4× 801 0.5× 1.3k 1.0× 1.2k 1.1× 359 0.6× 247 5.2k
Li Li China 43 3.9k 2.2× 1.5k 1.0× 1.2k 0.9× 1.7k 1.5× 451 0.8× 262 6.3k
Dalin He China 47 3.7k 2.1× 1.7k 1.1× 1.4k 1.0× 1.7k 1.6× 447 0.8× 275 6.5k
Xishan Hao China 40 2.6k 1.5× 1.0k 0.7× 1.6k 1.2× 1.6k 1.5× 755 1.3× 150 5.1k
Min Yuan China 32 2.3k 1.3× 677 0.5× 1.2k 0.9× 947 0.9× 608 1.1× 113 4.6k

Countries citing papers authored by Ming Li

Since Specialization
Citations

This map shows the geographic impact of Ming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Li more than expected).

Fields of papers citing papers by Ming Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Li. The network helps show where Ming Li may publish in the future.

Co-authorship network of co-authors of Ming Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Li. A scholar is included among the top collaborators of Ming Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Li. Ming Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Huijing, et al.. (2025). The immune microenvironment of pathogen-associated cancers and current clinical therapeutics. Molecular Cancer. 24(1). 232–232. 1 indexed citations
3.
Li, Ming, et al.. (2024). The expression of SLFN11 is related to the sensitivity of bladder cancer cells to DNA damage agents. Gene Reports. 34. 101881–101881. 1 indexed citations
4.
Yu, Lianbo, Lijuan Kang, Songtao Xue, et al.. (2024). 807MO High efficacy and safety of interleukin-6-knockdown CD19-targeted CAR-T cells in relapsed/refractory B-ALL patients. Annals of Oncology. 35. S599–S599. 1 indexed citations
5.
Li, Chao, Xiaoshu Chen, Zhongjun Du, et al.. (2024). Inhibiting ferroptosis in brain microvascular endothelial cells: A potential strategy to mitigate polystyrene nanoplastics‒induced blood‒brain barrier dysfunction. Environmental Research. 250. 118506–118506. 18 indexed citations
6.
Li, Ming, Sanju Sobnach, U. Kotze, et al.. (2024). Inflammatory myofibroblastic tumours of the liver – a systematic review. South African Journal of Surgery. 62(2). 121–129. 1 indexed citations
7.
Xu, Qiang, et al.. (2024). Keratin 6A (KRT6A) promotes radioresistance, invasion, and metastasis in lung cancer via p53 signaling pathway. Aging. 16(8). 7060–7072. 5 indexed citations
8.
Guo, Xinjian, Linyan Huang, Ming Li, et al.. (2024). Peroxynitrite-Triggered Carbon Monoxide Donor Improves Ischemic Stroke Outcome by Inhibiting Neuronal Apoptosis and Ferroptosis. Molecular Neurobiology. 61(12). 10629–10644. 4 indexed citations
10.
Liu, Bo, et al.. (2023). A study on the survival prediction for patients with oral cancer in southwest China. Oral Diseases. 30(3). 966–976. 5 indexed citations
11.
Bi, Guoshu, Jiaqi Liang, Guangyao Shan, et al.. (2023). Retinol Saturase Mediates Retinoid Metabolism to Impair a Ferroptosis Defense System in Cancer Cells. Cancer Research. 83(14). 2387–2404. 37 indexed citations
12.
Bar, Jair, Shobhit Baijal, Weidong Zhao, et al.. (2023). 1397P Prevalence, molecular characterization, and prognosis of MET–overexpressing non-small cell lung cancer (NSCLC) in a real-world patient cohort. Annals of Oncology. 34. S799–S800. 2 indexed citations
13.
Hu, Zhengyang, Xing Jin, Weifeng Hong, et al.. (2023). Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma. Cellular Oncology. 46(5). 1351–1368. 13 indexed citations
15.
Zhang, Shuai, Zhiyun Xu, Gaochao Dong, Ming Li, & Lin Xu. (2021). Analysis of Clinical Characteristics of Lung Cancer Combined with 
Multiple Primary Malignancies in Other Organs. SHILAP Revista de lepidopterología. 3 indexed citations
16.
Wang, Jing, Pengfei Kong, Haiyun Wang, et al.. (2020). Identification of a Gene-Related Risk Signature in Melanoma Patients Using Bioinformatic Profiling. Journal of Oncology. 2020. 1–13. 13 indexed citations
17.
Shi, Ruoshi, Ming Li, Vibha Raghavan, et al.. (2018). Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in PIK3CA -Mutant Lung Squamous Cell Carcinoma. Clinical Cancer Research. 24(23). 5990–6000. 20 indexed citations
19.
Du, Changzheng, Wei‐Cheng Xue, Yong Cai, Ming Li, & Jin Gu. (2009). Lymphovascular invasion in rectal cancer following neoadjuvant radiotherapy: A retrospective cohort study. World Journal of Gastroenterology. 15(30). 3793–3793. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026